Abstract: Methods of treating and evaluating subjects having neoactive mutants are described herein.
Type:
Grant
Filed:
May 8, 2017
Date of Patent:
April 7, 2020
Assignee:
Agios Pharmaceuticals, Inc.
Inventors:
Lenny Dang, Valeria Fantin, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Francesco G. Salituro, Jeffrey O. Saunders, Shin-San Michael Su, Katharine Yen
Abstract: A saturation indication system includes a sorbent body with a film backing being irreversibly bonded to the sorbent body. A universal indicating ink formulation is at least partially coated onto the film backing such that the ink formulation is disposed between the film backing and the sorbent body. The universal indicating ink formulation includes a resin and a dye dispersed in the resin. The dye is configured to indicate a state of saturation of the sorbent body, with the resin and the dye being soluble in a plurality of categories of sorbates consisting of hydrophobic sorbates, hydrophilic sorbates, neutral sorbates, and amphiphilic sorbates.
Type:
Grant
Filed:
May 8, 2017
Date of Patent:
March 31, 2020
Assignee:
Brady Worldwide, Inc.
Inventors:
Matthew Kasper, Michael Labelle, Nicholas Krogman, Bethany Grillo
Abstract: A method of selective detection of a concentration of a metal ion species in a subject is provided in which a biofluid sample is obtained from the subject. The biofluid sample is exposed to a functionalized porous aromatic polymer. The polymer selectively captures and concentrates the metal ion species from the biofluid. Subsequently, the biofluid is washed from the polymer. The polymer is then exposed to a solution comprising a colorimetric indicator that extracts the metal ion species from the washed polymer thereby changing a color of the solution as a function of an amount of the metal ion species in the polymer. The concentration of the metal ion species in the subject is then spectroscopically determined from the color of the solution.
Type:
Grant
Filed:
May 11, 2017
Date of Patent:
March 31, 2020
Assignee:
The Regents of The University of California
Inventors:
Christopher J. Chang, Jeffrey R. Long, Sumin Lee, Gokhan Barin
Abstract: Disclosed herein are methods of using serum nitric oxide levels to diagnose subjects as having or likely to develop a post-operative complication.
Type:
Grant
Filed:
April 8, 2016
Date of Patent:
March 24, 2020
Assignee:
The Regents of the University of California
Inventors:
Hua Cai, Kimberly Howard-Quijano, Aman Mahajan, Ji Youn Youn
Abstract: [Problem] To provide a method for acquisition of data able to serve as an index for determining the likelihood that an ovarian endometriosis cyst is cancerous. Solution This data acquisition method for determining the likelihood that an ovarian endometriosis cyst is cancerous includes an iron concentration measurement step for measuring the iron concentration in the cystic fluid of the ovarian endometriosis cyst. This diagnostic device for diagnosing the likelihood that an ovarian endometriosis cyst is cancerous is provided, at a minimum, with an iron concentration measurement unit for measuring the iron concentration in the cystic fluid of the ovarian endometriosis cyst.
Abstract: The present invention provides an endodermal cell production method that can induce differentiation of pluripotent cells into endodermal cells even when the pluripotent cells are dispersed and can achieve improved endodermal cell production efficiency. The endodermal cell production method according to the present invention is a method for producing endodermal cells by inducing differentiation of pluripotent cells into the endodermal cells, including the step of: inducing differentiation of the pluripotent cells into the endodermal cells in the presence of an endodermal cell inducing factor. In the induction step, the cell density of the pluripotent cells at the start of the induction preferably is from 0.5×104 to 2×104 cells/cm2.
Abstract: A method for detection and identification of a chemical using a preconcentrator to collect a sample of the chemical, process said sample of the chemical, and introduce said processed chemical into a chemical analysis instrument for the detection of and identification of the chemical. A system for detecting and identifying a chemical comprising a preconcentrator having at least dual concentrating elements.
Type:
Grant
Filed:
August 3, 2017
Date of Patent:
March 3, 2020
Assignee:
BAE Systems Information and Electronic Systems Integration Inc.
Inventors:
Michael J. Bowers, II, John E. King, Tadd C. Kippeny
Abstract: Embodiments of the invention are directed to a solid-state zinc sensor. A non-limiting example of the sensor includes a semiconductor substrate. The sensor can also include an assembly surface on the semiconductor substrate. The sensor can also include a zinc detection monolayer chemically bound to the assembly surface. The sensor can also include a power supply electrically connected to the semiconductor substrate.
Type:
Grant
Filed:
June 28, 2017
Date of Patent:
March 3, 2020
Assignee:
INTERNATIONAL BUSINESS MACHINES CORPORATION
Inventors:
Ali Afzali-Ardakani, Abram L. Falk, Bharat Kumar
Abstract: Novel systems and methods are provided that rapidly separate particles from a liquid. In an embodiment, a small volume of liquid (such as a blood sample, or any other solution with a concentration of particles) is input into a flow device implemented as a unilateral channel. When activated by an acoustic energy source (such as an ultrasound pulse), gas-liquid interfaces naturally occurring between the liquid in the flow device and a plurality of gas-filled cavities that line the channel will oscillate and create stable cavitation streaming within a localized region of the surrounding liquid. These oscillations create micro-vortices that gently remove and trap particles and debris from the liquid and adjacent surfaces. Fluid and particle manipulation can thus be accomplished on a passive, disposable chip that is placed on top of an external acoustic transducer with a coupling medium.
Type:
Grant
Filed:
May 24, 2013
Date of Patent:
February 18, 2020
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
Arlene Doria, Maulik Patel, Nicholas E Martin, Yuka Okabe, Abraham Lee
Abstract: Methods and kits for determining, predicting, or diagnosing pulmonary artery hypertension (PAH) and for determining the efficacy of PAH therapy using biomarkers are provided.
Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
Type:
Grant
Filed:
July 1, 2015
Date of Patent:
February 11, 2020
Assignee:
Theranos IP Company, LLC
Inventors:
Elizabeth A. Holmes, Michael Chen, John K. Frankovich, Samartha Anekal, Adrit Lath, Alexander Loo, Chinmay Pangarkar, Joy Roy, Timothy Smith, Daniel Young
Abstract: A system for generating data relating to a tissue core comprises a core needle biopsy module configured to obtain a tissue core from a locus within the body, and a tissue disintegration module operably connected to the core needle biopsy module and configured to receive a tissue core from the core needle biopsy module and convert at least a portion of the tissue core into gaseous tissue molecules. The system also comprises first vacuum pump means configured to convey a tissue core from the needle biopsy module to the tissue disintegration module, and second vacuum pump means configured to convey gaseous tissue molecules from the tissue disintegration module to an analyser module.
Abstract: The present invention relates to systems and methods of determining quality compliance for a set of biological sample testing devices used with one or more test instruments at the point-of-care in a hospital or other location that delivers medical care. In particular, the systems and methods ensure that only biological sample testing devices that pass a quality assurance protocol are used for point-of-care testing.
Abstract: An analyzing device having a microchannel structure includes a sample inlet and a guide section extending from the sample inlet toward an axial center. The analyzing device further includes a first cavity connected to the guide section and configured to measure a certain amount of a sample liquid, and a receiving cavity located adjacent to the first cavity and receiving the sample liquid. The analyzing device further includes a liquid reservoir formed between the sample inlet and the guide section and temporarily holds the sample liquid before being suctioned into the guide section. The sample liquid temporarily held in the liquid reservoir is transferred from the liquid reservoir to the guide section and the first cavity by a capillary force and transferred to the receiving cavity by a centrifugal force caused by rotating the analyzing device about the axial center.
Abstract: In the thermochemical water splitting process by the Cu—Cl cycle, oxygen gas is produced by a thermolysis process in a three-phase reactor. A precise knowledge of the hydrodynamic and heat transfer analyses is required for the scale-up of the thermolysis reactor. However, in the experimental studies of the scale up analysis, there are some challenges in using the actual materials of the thermolysis reactor products (i.e. molten salt CuCl and oxygen gas). In accordance with the teachings herein, alternative materials are defined, by using dimensional analyses, to simulate the hydrodynamic and heat transfer behaviors of the actual materials. It has been found that these alternative materials are liquid water at 22±2° C. and helium gas at 90±2° C. The alternative materials provide safe environment for the experimental runs as well as lower operating temperature. Furthermore, these alternative materials are more readily available and are low cost.
Abstract: A biological sample collection device can include a sample collection vessel having a sample collection chamber with an opening configured to receive a biological sample into the sample collection chamber. The sample collection chamber can also include elongate ridges disposed along and projecting inwardly from an interior portion thereof. The sample collection vessel can also include a connection member disposed on an exterior portion and a fluid reservoir. The fluid reservoir can include a reagent chamber having an open end and a closed end with an elongate member disposed at the closed end that is sized and shaped to engage the elongate ridges of the sample collection vessel when arranged within the fluid reservoir. The sample collection vessel can also include a sealing cap having internal threads for engaging external threads of the fluid reservoir and a complementary connection member to couple the sample collection vessel and the sealing cap.
Abstract: Provided is a novel method of suppressing non-specific protein adsorption. The above-mentioned object can be achieved by treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component, and treating a specimen with a specimen-treating liquid containing, as a main component, a polymer having a phosphorylcholine group, a hydroxy group, and a hydrophobic group, followed by addition of the treated specimen to the treated solid phase.
Type:
Grant
Filed:
February 18, 2016
Date of Patent:
December 31, 2019
Assignees:
National University Corporation Kyoto Institute of Technology, NOF Corporation
Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
Type:
Grant
Filed:
February 10, 2017
Date of Patent:
December 31, 2019
Assignee:
Theranos IP Company, LLC
Inventors:
Elizabeth A. Holmes, Joy Roy, John Kent Frankovich
Abstract: A test apparatus is provided for rapidly detecting abnormal loading of a microfluidic device, and unloading the abnormally-loaded microfluidic device, thereby preventing contamination of the test apparatus by a sample and degradation in reliability of test results. A test system including the test apparatus and a control method for the test apparatus are also provided. The test apparatus includes an optical sensor to photograph an image at a position corresponding to the microfluidic device, and a controller to detect a pattern formed on a surface of the microfluidic device based on the photographed image to determine whether characteristics of the detected pattern are identical to characteristics of a pre-stored pattern, and to determine whether the microfluidic device has not been normally loaded, when the characteristics of the detected pattern are different from the characteristics of the pre-stored pattern.
Type:
Grant
Filed:
June 28, 2013
Date of Patent:
December 31, 2019
Assignee:
NEXUS DX, INC.
Inventors:
Jung Tae Lee, Chung Ung Kim, Young Goun Lee, Jin Beom Hong
Abstract: Embodiments of the present disclosure provide for methods for detecting the presence and/or concentration of anions in a solution, systems for detecting the presence and/or concentration of anions in a solution, anion sensor systems, and the like.
Type:
Grant
Filed:
February 11, 2016
Date of Patent:
December 24, 2019
Assignee:
KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors:
Dilshad Masih, Omar F. Mohammed, Shawkat M. Aly, Erkki Alarousu